2012/08/01 by Rita Shane · 1 citation
Medicine · #Pharmaceutical Practices and Patient Outcomes #Medication Adherence and Compliance #Pharmaceutical studies and practices
paper · doi:10.2146/ajhp120292
openalex publication_date 2012/08/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
Thank you for the privilege of being here tonight to follow in the footsteps of the exceptionally talented and dedicated pharmacy leaders who preceded me. ASHP has provided me with numerous opportunities to learn, to collaborate, to develop lifelong friendships, to grow professionally throughout my career, and, most importantly, to advance the care of patients. I feel incredibly honored to receive this recognition. To my family, staff, residents, friends, and colleagues: You have inspired me and nurtured my love for this profession. I must admit that I fell for pharmacy before I fell for my husband. My residents this year created a slogan that states “Must Love Pharmacy,” since it is a key criterion we use in selecting pharmacy staff members. As I started my journey through the collection of Harvey A. K. Whitney Award lectures, Paul Abramowitz reminded me that after the Pharmacy Practice Model Summit in November 2010, I had remarked that the time had come for an Institute of Medicine (IOM) report to examine our current and future roles and to indelibly imprint pharmacists as an essential component of health care delivery models. I am optimistic that, at some point, we will have the opportunity to become the subject of or substantially contribute to an IOM report that addresses the essential role of pharmacists in optimizing medication use. In the interim, I will use the IOM process as a framework in which to provide my remarks, which I will call the Institute of Pharmacy report.